OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction (OMEGA)
Myocardial Infarction
About this trial
This is an interventional treatment trial for Myocardial Infarction focused on measuring myocardial infarction, omega 3-fatty acids
Eligibility Criteria
Inclusion Criteria: Myocardial infarction 3-14 days before randomisation (STEMI and NSTEMI) Ability to take Ω-3-FAE or olive oil without risk Informed consent Exclusion Criteria: Premenopausal women who are not surgically sterile, who are pregnant or nursing, who are of child-bearing potential and are not practising acceptable means of birth control (pregnancy testing required before randomisation) Known hypersensitivity to study medication Dislike of fish oil Haemorrhagic diathesis Unwillingness to discontinue other medications containing fish oil Legal incapacity History of drug or alcohol abuse within 6 months Any investigational therapy within one month of signing informed consent form
Sites / Locations
- Klinikum der Stadt Ludwigshafen gGmbH
- Johanniter-Krankenhaus Rheinhausen
- Elisabeth-Krankenhaus
- Staedt. Kliniken Frankfurt/Main-Hoechst
- Klinikum Fuerth
- Universitaetsklinikum Heidelberg
- Klinikum Ingolstadt
- Klinikum Neustadt
- Elisabeth-Krankenhaus
- Marienkrankenhaus
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
1
2
omega-3-acid ethyl ester 90
olive oil